Related references
Note: Only part of the references are listed.How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness
Ben Kearns et al.
PHARMACOECONOMICS (2020)
A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity
Tim S. Grant et al.
PHARMACOECONOMICS (2020)
Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection
Ash Bullement et al.
BMC MEDICAL RESEARCH METHODOLOGY (2020)
Estimating the loss of lifetime function using flexible parametric relative survival models
Lasse H. Jakobsen et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
Mario J. N. M. Ouwens et al.
PHARMACOECONOMICS (2019)
Generalized Linear Models for Flexible Parametric Modeling of the Hazard Function
Benjamin Kearns et al.
MEDICAL DECISION MAKING (2019)
A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement
Helen Bell Gorrod et al.
MEDICAL DECISION MAKING (2019)
Using simulation studies to evaluate statistical methods
Tim P. Morris et al.
STATISTICS IN MEDICINE (2019)
How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017
Daniel Gallacher et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2019)
Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation
Eddie Gibson et al.
PHARMACOECONOMICS (2017)
Survival Analysis for Economic Evaluations Alongside Clinical Trials-Extrapolation with Patient-Level Data: Inconsistencies, Limitations, and a Practical Guide
Nicholas R. Latimer
MEDICAL DECISION MAKING (2013)
Estimating and modeling the cure fraction in population-based cancer survival analysis
Paul C. Lambert et al.
BIOSTATISTICS (2007)
Share Paper
